Familial inflammatory inclusion body myositis

Annals of the Rheumatic Diseases

Volumn 64, Issue 4, 2005, Pages 634-637

  Ranque Francois, B ^a   Maisonobe, T ^a   Dion, E ^a   Piette, J C ^a   Chauveheid, M P ^a   Amoura, Z ^a   Papo, T ^a  

^a PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

CONGO RED; HLA DR ANTIGEN; IMMUNOGLOBULIN; OXIDOREDUCTASE; STEROID;

ADIPOSE TISSUE; AGED; ARTICLE; CASE REPORT; CELL INFILTRATION; CELL ULTRASTRUCTURE; CLINICAL FEATURE; EDEMA; FAMILIAL DISEASE; FAMILIAL INFLAMMATORY INCLUSION BODY MYOSITIS; FEMALE; FOLLOW UP; GENETIC DISORDER; HAPLOTYPE; HEREDITARY INCLUSION BODY MYOPATHY; HISTOLOGY; HUMAN; INCLUSION BODY MYOSITIS; INFLAMMATION; MALE; MONONUCLEAR CELL; MUSCLE BIOPSY; MUSCLE WEAKNESS; MYOPATHY; NUCLEAR MAGNETIC RESONANCE IMAGING; ONSET AGE; PRIORITY JOURNAL; QUADRICEPS FEMORIS MUSCLE; SIBLING; SPORADIC INCLUSION BODY MYOSITIS; SYMPTOM;

AGED; FEMALE; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; MUSCLE, SKELETAL; MYOSITIS, INCLUSION BODY; PEDIGREE; THIGH;

EID: 16344371414     PISSN: 00034967     EISSN: None     Source Type: Journal    
DOI: 10.1136/ard.2004.025494     Document Type: Article

References (15)

1. Askanas V, Engel WK. Sporadic inclusion-body myositis and hereditary inclusion body-myopathies: diagnosis and pathogenesis. Curr Opin Rheumatol 1998;10:530-42.
2. Dalakas MC. Understanding the immunopathogenesis of inclusion body myositis: present and future prospects. Rev Neurol 2003;158:948-58.
3. Tome FM, Fardeau M. Hereditary inclusion body myopathies. Curr Opin Neurol 1998;11:453-9.
4. Eisenberg I, Avidan N, Potikha T, Hochner H, Chen M, Olender T, et al. The UDP-N-acetylglucosamine 2-epimerase/N-acetylmannosamine kinase gene is mutated in recessive hereditary inclusion body myopathy. Nat Genet 2001;29:83-7.
5. Argov Z, Eisenberg, Mitrani-Rosenbaum S. Genetics of inclusion body myopathies. Curr Opin Rheumatol 1998;10:543-7.
6. Amata AA, Shebert RT. Inclusion body myositis in twins. Neurology 1998;51:598-600.
7. Sivakumar K, Semino-Mora C, Dalakas MC. An inflammatory, familial, inclusion body myositis with autoimmune features and a phenotype identical to sporadic inclusion body myositis. Study in three families. Brain 1997;120:653-61.
8. Naumann NM, Reichmann H, Goebel HH, Moll C, Tockya KV. Glucocorticoid-sensitive hereditary inclusion body myositis. J Neurol 1996;243:126-30.
9. Rider LG, Gurley RC, Pandey JP, de la Torre IG, Kalovidouris AE, O'Hanlon TP, et al. Clinical, serologic, and immunogenetic features of familial idiopathic, inflammatory myopathy. Arthritis Rheum 1998;41:710-19.
10. Garlepp MJ, Laing B, Zilko J, Ollier W, Mastaglia FL. HLA associations with inclusion body myositis. Clin Exp Immunol 1994;98:40-5.
11. Koffman BM, Sivakumar K, Simonis T, Stroncek D, Dalakas MC. HLA allele distribution distinguishes sporadic inclusion body myositis from inclusion body myopathies. J Neuroimmunol 1998;842:139-42.
12. Fyhr IM, Moslemi AR, Mosavi AA, Lindberg C, Tarkowski A, Oldfors A. Oligoclonal expansion of muscle infiltrating T cells in inclusion body myositis. J Neuroimmunol 1997;9:185-9.
13. Dalakas MC, Koffman B, Fujii M, Spector S, Sivakumar K, Cupler E. A controlled study of intravenous immunoglobulin combined with prednisone in the treatment of inclusion body myositis. Neurology 2001;56:323-7.
14. Dalakas MC. Controlled studies with high-dose intravenous immunoglobulin in the treatment of dermatomyositis, inclusion body-myositis and polymyositis. Neurology 1998;51(suppl 5):S37-45.
15. Walter MC, Lochmuller H, Toepfer M, Schlotter B, Reilich P, Schroder M, et al. High dose immunoglobulin treatment in sporadic inclusion body myositis: a controlled study. J Neurol 2000;247:22-8.